Psychopharmacologic treatment of schizophrenia

Schizophrenia Bulletin

Volumn 19, Issue 2, 1993, Pages 287-302

  Kane, John M ^a   Marder, Stephen R ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATROPINE MESILATE; CHLORPROMAZINE; CLOZAPINE; DOPAMINE RECEPTOR; FLUPHENAZINE; HALOPERIDOL; MELPERONE; NEUROLEPTIC AGENT; RISPERIDONE; RITANSERIN; SEROTONIN; SEROTONIN RECEPTOR;

AGRANULOCYTOSIS; AKATHISIA; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; MAINTENANCE THERAPY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RATING SCALE; REVIEW; SCHIZOIDISM; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

ANTIPSYCHOTIC AGENTS; HUMAN; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0027178496     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/schbul/19.2.287     Document Type: Article

References (0)